suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - schweine - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
dalacin c 150 mg - kapseln
pfizer corporation austria gmbh - clindamycin hydrochlorid - clindamycin
dalacin c 300 mg - kapseln
pfizer corporation austria gmbh - clindamycin hydrochlorid - clindamycin
dalacin c 75 mg/5 ml - granulat für orale lösung
pfizer corporation austria gmbh - clindamycin palmitat hydrochlorid - clindamycin
dalacin c phosphat 300 mg/2 ml - ampulle
pfizer corporation austria gmbh - clindamycin phosphat - clindamycin
dalacin c phosphat 600 mg/4 ml - ampulle
pfizer corporation austria gmbh - clindamycin phosphat - clindamycin
dalacin c phosphat 900 mg/6 ml - ampulle
pfizer corporation austria gmbh - clindamycin phosphat - clindamycin
clindamycin 300 - 1 a pharma
1 a pharma gmbh (8013083) - clindamycinhydrochlorid 1 h<2>o - hartkapsel - teil 1 - hartkapsel; clindamycinhydrochlorid 1 h<2>o (07145) 348,4 milligramm
clindamycin-ratiopharm 600 mg filmtabletten
ratiopharm gmbh (3087881) - clindamycinhydrochlorid - filmtablette - teil 1 - filmtablette; clindamycinhydrochlorid (03812) 688 milligramm
clindahexal 150
h e x a l aktiengesellschaft (3079284) - clindamycinhydrochlorid 1 h<2>o - hartkapsel - teil 1 - hartkapsel; clindamycinhydrochlorid 1 h<2>o (07145) 174,2 milligramm